On the other hand, treatment of neuroblastoma cells with 200 μM PA did not affect cell viability but blocked insulin-induced metabolic activation, inhibited the activation of the insulin/PI3K/Akt pathway, and activated mTOR kinase [77]. This evidence concerns the gene INS and neuroblastoma.